SUZHOU, China, Dec. 30, 2024 /PRNewswire/ -- Hangzhou Sino-US Huadong Medicine Co., Ltd. (hereinafter referred to as "Huadong Medicine"), a wholly-owned subsidiary of Huadong Medicine Co., Ltd. (SZ.000963), and SynerK PharmaTech (Suzhou) Co., Ltd. (hereinafter referred to as "SynerK")...
Hence then, the article about huadong medicine co ltd and synerk reached a strategic cooperation to jointly develop a novel sirna drug snk 2726 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Huadong Medicine Co., Ltd. and SynerK reached a strategic cooperation to jointly develop a novel siRNA drug SNK-2726 )
Also on site :
- Atalanta vs Parma: How to Watch Live, Match Time and TV Channels
- Conrad Hilton died in 1979, leaving the bulk of his hotel fortune to charity and just $10,000 each to his nieces and nephews
- In the 1950s, Roger Baillon began collecting vintage cars that rusted in sheds for decades; they sold for 25 million euros in 2015